ArticleFrontiers in cardiovascular medicine2026
Clinical outcomes of external fenestration TEVAR in Stanford type B aortic dissection involving the left subclavian artery: a retrospective study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study assessed the clinical efficacy and hemodynamic effects of external fenestration thoracic endovascular aortic repair (TEVAR) in patients with type B aortic dissection (TBAD) involving the left subclavian artery (LSA). Methods: A retrospective analysis of 110 patients who underwent this procedure between 2020 and 2024 was conducted, evaluating procedural success, complications, and follow-up outcomes. Hemodynamic changes were analyzed in 1 patient using computational fluid dynamics (CFD) based on pre- and postoperative CT angiography (CTA). Results: Technical success was achieved in all cases. Complications included 3 cases of type I endoleak (2.7%), 1 type II endoleak (0.9%), 3 type IV endoleak (2.7%), 1 LSA stenosis (0.9%), and 2 deaths (1.8%). At a 5.7-month follow-up, 92.7% of patients showed complete false lumen thrombosis. There were occurrences of type I endoleak (2.7%), type II endoleak (1.8%), type IV endoleak (2.7%), LSA occlusion (2.7%), and LSA stenosis (2.7%). CFD analysis in the representative case demonstrated restoration of physiological flow patterns, including normalized streamlines in the LSA and stabilized wall shear stress in the stented segment. Conclusion: External fenestration TEVAR demonstrates favorable clinical outcomes and hemodynamic stability in TBAD involving the LSA, effectively promoting false lumen thrombosis and aortic remodeling while preserving LSA perfusion. Our findings suggest that complete entry coverage with an adequate proximal landing zone (≥15 mm when anatomically feasible) may be important for achieving false lumen depressurization, although this observation requires further validation. Further prospective studies are warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.